Coral Sea Clinical Research Institute

 
CSCRI-Banner-4.jpg

Keep up to date with the latest information from the Coral Sea Clinical Research Institute. For media enquiries, please contact admin@coralseaclinical.com

 

Media resources about CSCRI trials

 
 

Recruitment Open for Coeliac Patients in The Mackay, Whitsundays and Coalfields Regions. 

08 August 2023

https://fb.watch/mhS1o6rmnm/?mibextid=5eVWNK

 

Beyond The Wheat Barrier: Individuals Needed For Coeliac Clinical Trial

04 August 2023

https://www.mackayandwhitsundaylife.com/article/beyond-the-wheat-barrier-individuals-needed-for-coeliac-clinical-trial

Featured
Coeliac disease vaccine trials

www.coeliac.org.au

The vaccine aims to protect patients from the harmful effects of gluten

A WORLD-FIRST coeliac disease vaccine is being tested which aims to end the need for gluten-free diets.

Shireen Khalil, news.com.au

Vaccine for coeliac disease being trialled at Australian hospitals

www.adelaidenow.com.au

The research that could end Coeliac disease

The Chronicle, by Shireen Khalil

ImmusanT Initiates Phase 2 Enrollment for its Lead Therapeutic Vaccine Candidate in Patients With Celiac Disease in Australia and New Zealand

ImmusanT, Inc., a clinical stage company leveraging its Epitope-Specific Immuno-Therapy™ (ESIT™) platform to deliver first-in-class peptide-based immunomodulatory vaccine therapies to patients with autoimmune diseases, initiated enrollment in Australia and New Zealand for its Phase 2 RESET CeD study assessing the safety, tolerability and efficacy  of its lead therapeutic candidate, Nexvax2®, in patients with celiac disease who carry the immune recognition genes for HLA-DQ2.5.

Read More >

View more articles here.

 

More information on Coeliac Disease

Coeliac Australia

Coeliac Queensland

Coeliac disease education resource
Queensland Government (September 2017)

 

For media enquiries, please contact admin@coralseaclinical.com.